THOMPSON PETER A. enters PREVAIL THERAPEUTICS INC. with 2.43M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 6/19/2019ACC: 0001209191-19-038131
Director10% Owner
Since Jun 2019
2.43M
Baseline shares
0.00
Direct ownership
0 positions
10.51M
Derivative underlying
3 instruments
1
Security positions
2.43M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned2.43M
Total
2.43M indirect2.43M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.43M | Indirect |
| Total | 2.43M | 2.43M indirect |
Derivative Holdings3
Series Seed Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
6.40M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series B Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
1.01M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
3.10M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
10.51M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series Seed Preferred Stock Indirect | Common Stock | — | — | 6.40M | N/A | |
| Series B Preferred Stock Indirect | Common Stock | — | — | 1.01M | N/A | |
| Series A Preferred Stock Indirect | Common Stock | — | — | 3.10M | N/A | |
| Total | 10.51M | 0.00 | ||||